CME Group Inc. (NASDAQ:CME) Shares Acquired by CCLA Investment Management

CCLA Investment Management grew its holdings in CME Group Inc. (NASDAQ:CME) by 1.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 539,237 shares of the financial services provider’s stock after acquiring an additional 5,493 shares during the quarter. CCLA Investment Management’s holdings in CME Group were worth $105,396,000 at the end of the most recent reporting period.

Several other institutional investors have also recently modified their holdings of the company. Bluefin Capital Management LLC purchased a new position in CME Group during the fourth quarter valued at approximately $2,891,000. Alaska Permanent Fund Corp raised its position in CME Group by 81.4% during the first quarter. Alaska Permanent Fund Corp now owns 44,534 shares of the financial services provider’s stock valued at $9,588,000 after acquiring an additional 19,985 shares in the last quarter. Bank of Nova Scotia raised its position in CME Group by 229.4% during the fourth quarter. Bank of Nova Scotia now owns 292,597 shares of the financial services provider’s stock valued at $61,618,000 after acquiring an additional 203,769 shares in the last quarter. Oak Harvest Investment Services raised its position in CME Group by 66.5% during the first quarter. Oak Harvest Investment Services now owns 45,093 shares of the financial services provider’s stock valued at $9,708,000 after acquiring an additional 18,017 shares in the last quarter. Finally, PNC Financial Services Group Inc. raised its position in CME Group by 189.5% during the fourth quarter. PNC Financial Services Group Inc. now owns 131,872 shares of the financial services provider’s stock valued at $27,772,000 after acquiring an additional 86,325 shares in the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the transaction, the chief financial officer now directly owns 13,261 shares in the company, valued at approximately $2,877,504.39. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

CME has been the subject of several recent research reports. Bank of America cut CME Group from a “neutral” rating to an “underperform” rating and reduced their price target for the company from $212.00 to $177.00 in a research report on Tuesday, September 3rd. Keefe, Bruyette & Woods lifted their price target on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research report on Thursday, July 25th. Piper Sandler restated an “overweight” rating and issued a $225.00 price objective on shares of CME Group in a research report on Tuesday, August 20th. Barclays boosted their price objective on CME Group from $208.00 to $209.00 and gave the company an “equal weight” rating in a research report on Thursday, July 25th. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a research report on Thursday, August 15th. Four research analysts have rated the stock with a sell rating, five have issued a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $209.73.

CME Group Stock Performance

Shares of NASDAQ:CME opened at $218.18 on Wednesday. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02. The business’s 50 day moving average price is $206.63 and its 200-day moving average price is $207.48. The firm has a market capitalization of $78.56 billion, a PE ratio of 24.82, a P/E/G ratio of 8.85 and a beta of 0.55. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $223.80.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.53 by $0.03. The firm had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.53 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The business’s revenue was up 12.7% on a year-over-year basis. During the same period in the previous year, the company posted $2.30 earnings per share. As a group, equities research analysts expect that CME Group Inc. will post 9.94 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th will be paid a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a yield of 2.11%. The ex-dividend date of this dividend is Monday, September 9th. CME Group’s dividend payout ratio (DPR) is currently 52.33%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.